可降解吻合器在肠道手术中的应用效果分析OA
Clinical efficacy of biodegradable anastomotic device in intestinal surgery
目的 探讨可降解吻合器在肠道手术中的临床应用价值.方法 以2020年8月至2024年8月在我院进行肠道手术的100例患者为研究对象,按随机数字表法将其分为可降解吻合器组(n=50)和传统吻合器组(n=50).比较2组患者术后1个月内并发症发生率及病死率;比较2组患者术后肛门不适感视觉模拟量表(VAS)评分、排便习惯、生活质量综合评定问卷(GQOLI-74)评分、住院时间、医疗成本及满意度.结果 入组的100例患者均完成肠道手术及术后随访,无患者失访.可降解吻合器组患者术后1个月内并发症总发生率低于传统吻合器组(P<0.05);2组患者术后1个月内病死率比较,差异无统计学意义(P>0.05).术后1个月,2组患者肛门不适感VAS评分均低于术后24 h(P<0.05),可降解吻合器组患者肛门不适感VAS评分低于传统吻合器组(P<0.05).术后1个月,2组患者每日排便次数少于术后24 h(P<0.05),非正常排便性状、排便费力、便意不尽感患者比例均低于术后24 h(P<0.05),可降解吻合器组患者每日排便次数少于传统吻合器组(P<0.05),非正常排便性状、便意不尽感患者比例均低于传统吻合器组(P<0.05).术后1个月,2组患者躯体功能、心理功能、社会功能、物质生活状态评分及GQOLI-74总评分均高于术后24 h(P<0.05),且可降解吻合器组上述指标评分均高于传统吻合器组(P<0.05).可降解吻合器组患者住院时间显著短于传统吻合器组(P<0.05),医疗成本显著低于传统吻合器组(P<0.05),术后满意度优于传统吻合器组(P<0.05).结论 可降解吻合器在降低肠道手术患者术后并发症发生率、改善排便习惯及生活质量方面均优于传统吻合器,可缩短肠道手术患者住院时间,减少医疗成本,并提高整体满意度.
Objective To investigate the clinical application value of biodegradable anastomotic device in intestinal surgery.Methods A total of 100 patients who underwent intestinal surgery in our hospital from August 2020 to August 2024 were enrolled and randomly divided into the biodegradable anastomotic device group(n=50)and the conventional anastomotic device group(n=50)using a random number table method.The incidence of complications and mortality within 1 month after surgery,visual analogue scale(VAS)score of postoperative anal discomfort,defecation habits,generic quality of life inventory-74(GQOLI-74)score,length of hospital stay,medical costs and satisfaction were compared between the two groups.Results All 100 enrolled patients completed intestinal surgery and postoperative follow-up without loss to follow-up.The total incidence of complications within 1 month after surgery in the biodegradable anastomotic device group was lower than that in the conventional anastomotic device group(P<0.05).There was no significant difference in mortality within 1 month after surgery between the two groups(P>0.05).At 1 month after surgery,the VAS scores of anal discomfort in both groups were lower than those at 24 hours after surgery(P<0.05),and the VAS score in the biodegradable anastomotic device group was lower than that in the conventional anastomotic device group(P<0.05).At 1 month after surgery,the daily defecation frequencies in both groups were lower than those at 24 hours after surgery(P<0.05),and the proportions of patients with abnormal stool consistency,difficult defecation and sensation of incomplete defecation were lower than those at 24 hours after surgery(P<0.05).The daily defecation frequency in the biodegradable anastomotic device group was lower than that in the conventional anastomotic device group(P<0.05),and the proportions of patients with abnormal stool consistency and sensation of incomplete defecation were lower than those in the conventional anastomotic device group(P<0.05).At 1 month after surgery,the scores of physical function,psychological function,social function,material life status and total GQOLI-74 score in both groups were higher than those at 24 hours after surgery(P<0.05),and the scores of all the above indicators in the biodegradable anastomotic device group were higher than those in the conventional anastomotic device group(P<0.05).Compared with the conventional anastomotic device group,the biodegradable anastomotic device group had a significantly shorter length of hospital stay,lower medical costs and higher postoperative satisfaction(P<0.05).Conclusion Biodegradable anastomotic device is superior to conventional anastomotic device in reducing the incidence of postoperative complications,improving defecation habits and quality of life in patients undergoing intestinal surgery,which can shorten the length of hospital stay,reduce medical costs and improve overall satisfaction.
姚粮;张淇惠;姬海亮
黑龙江省第二医院普外科,黑龙江 哈尔滨 150001黑龙江省第二医院普外科,黑龙江 哈尔滨 150001黑龙江省第二医院普外科,黑龙江 哈尔滨 150001
医药卫生
肠道手术可降解吻合器术后并发症生活质量
intestinal surgerybiodegradable anastomotic devicepostoperative complicationsquality of life
《局解手术学杂志》 2026 (6)
539-543,5
黑龙江省卫生健康委科研课题(20240404010488)
评论